Desde el 16 de mayo al 15 de septiembre el museo Artequin en Santiago de Chile presentará “Parte x Parte. Piezas para un ...

'La gran visión italiana. Colección Farnesina', exposición del Museo de Arte Moderno, es una muestra amplia y significativa ...

Moderna’s waiting for the FDA to give it a nod for its next potential blockbuster -- an RSV vaccine. But the FDA is taking longer than planned to review the vaccine candidate. The RSV vaccine ...

Investors have worried about Moderna’s growth prospects as demand for its coronavirus vaccine declines. Moderna may have a new billion-dollar product right around the corner. But things may be ...

Plunging sales of Moderna’s breakthrough COVID-19 vaccine have touched off a Wall Street debate about the future of a biotech company once seen as the brightest star in the Massachusetts drug ...

Image: Zed Jameson/Bloomberg News A federal court may soon order Moderna, the biotech company and vaccine manufacturer, to pay hefty damages to two smaller companies. The Biden administration ...

Moderna Chief Executive Stephane Bancel thinks Covid booster uptake this fall could be better than last fall’s disappointing levels. (Adam Glanzman/Bloomberg News) Moderna shares shot up about 7 ...

The Cambridge, Massachusetts-based company is banking on its experimental shots to make up for plunging demand for Moderna's Spikevax COVID-19 vaccine, its only marketed product. Moderna shares ...

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Moderna MRNA will report first-quarter 2024 results on May 2, before the opening bell. In the last reported quarter, the company reported an earnings surprise of 170.51%. The Zacks Consensus ...

Three years ago, Moderna, flush with cash from Covid vaccine sales, announced it would start investing in the burgeoning field of gene editing. It created a new division called Moderna Genomics ...

CAMBRIDGE, MA / ACCESSWIRE / May 13, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: Bernstein's 40th Annual Strategic ...